Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
Background. KL-6 is a biomarker of interstitial lung injury and increases during repair. Aim. Our aim was to determine the predictive value of plasma KL-6 for the development of bronchopulmonary dysplasia (BPD) in preterm infants. Methods. Ninety-five extremely preterm infants (EPIs), born at <28...
Main Authors: | Petya Radulova, Margaritka Boncheva, Gencho Nachev, Boriana Slancheva, Violeta Dimitrova |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2024-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2024/3623948 |
Similar Items
-
The Airway Microbiome and Metabolome in Preterm Infants: Potential Biomarkers of Bronchopulmonary Dysplasia
by: Qi Xu, et al.
Published: (2022-05-01) -
Invasive mechanical ventilation and biomarkers as predictors of bronchopulmonary dysplasia in preterm infants
by: Camila Piqui Nascimento, et al.
Published: (2021-05-01) -
Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
by: Tobias Muehlbacher, et al.
Published: (2021-04-01) -
The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants
by: Yanping Xu, et al.
Published: (2022-05-01) -
Initial respiratory management in preterm infants and bronchopulmonary dysplasia
by: Ester Sanz López, et al.
Published: (2011-01-01)